13 April 2021
Avingtrans Plc
("Avingtrans" or the "Company" or the "Group")
Exercise of Options and Total Voting Rights
Avingtrans plc, which designs, manufactures and supplies critical components, modules and associated services to the energy and medical sectors, announces that it has applied for 33,000 new ordinary shares of 5 pence each ("Ordinary Shares") in the Company to be admitted to trading on AIM on 16 April 2021 following an exercise of share options.
Following the issue of the 33,000 new Ordinary Shares the Company will have a total of 31,971,307 Ordinary Shares in issue. The Company does not hold any shares in Treasury.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
| Avingtrans plc | 01354 692391 |
| Roger McDowell, Chairman Steve McQuillan, Chief Executive Officer Stephen King, Chief Financial Officer | |
| N+1 Singer (Nominated Adviser) | 02074 963000 |
| Shaun Dobson/Alex Bond (Corporate Finance) Rachel Hayes (Corporate Broking) | |
| SEC Newgate (Financial PR) | 02076 539850 |
| Adam Lloyd/ Tom Carnegie | |
About Avingtrans plc:
Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.
Business units
Hayward Tyler - Luton & East Kilbride, UK and USA, China and India
Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.
Energy Steel, Inc - Lapeer, Michigan, USA
Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications;
engineering design solutions; product refurbishment; on-site technical support.
Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China
Provider of safety-critical equipment for the energy, medical, science and research communities,
worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub- assemblies and systems.
Booth Industries - Bolton, UK
Designs, manufactures, installs and services doors and walls which can be tailored to be: blast
&explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above
Ormandy Group, Bradford, UK
Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products
Composite Products Ltd - Buckingham, UK
Centre for composite technology, parts and assemblies, serving customers in industrial markets.
Scientific Magnetics - Abingdon, UK
Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI
and provides services for Nuclear Magnetic Resonance instruments.
Tecmag Inc, Houston, USA
Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for
Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.
Magnetica Ltd - Brisbane, Australia
Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has remained at the
forefront of MRI systems technology, successfully designing and commercialising a 1.5 Tesla extremity MRI superconducting magnet that is now the heart of over two hundred MRI systems world-wide. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system,
demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
